Updated on 31 October 2013
Focused on product development, the new AB Sciex R&D center is designed to enhance product quality and deliver incremental cost savings
Singapore: AB Sciex, a global firm in analytical technologies, has opened a new R&D center in Singapore.
The facility is an extension of the company's $10 million global operations in Marsiling where the life science industry's leading analytical instruments, including the AB SCIEX 6500 series and TripleTOF series, are manufactured.
Focused on product development, the new AB Sciex R&D center is designed to enhance product quality and deliver incremental cost savings while reducing delivery time to AB SCIEX customers. Since a pre-opening roll-out phase started a year ago, the center has helped the company realize $1.6 million in savings.
As a global leader in scientific technologies for biological and chemical analysis, AB Sciex spends close to 10 percent of its annual revenues on R&D, which is a driving force for the company's continued innovation in LC/MS/MS (liquid chromatography/tandem mass spectrometry).
The company has also invested in an application support and training facility in the Biopolis, which is Singapore's state-of-the-art biomedical research hub housing a community of public and private researchers.